Alphalan contains Melphalan, an alkylating antineoplastic medicine belonging to the nitrogen mustard class. It is used in specific chemotherapy protocols for the treatment of certain hematological malignancies and solid tumors.

Melphalan works by chemically modifying and cross-linking DNA, interfering with DNA replication and cell division. This action helps inhibit the growth and survival of susceptible malignant cells.

Melphalan may be used alone or in combination with other anticancer medicines, depending on the diagnosis and treatment protocol.

What is Melphalan?

Melphalan is a cytotoxic alkylating agent that damages the DNA of cancer cells. It has an established role in the management of multiple myeloma and is also used in selected other malignancies and high-dose chemotherapy protocols.

Benefits / Uses

Alphalan (Melphalan) may be used as part of treatment protocols for:

• Multiple myeloma
• Ovarian cancer
• Selected hematological malignancies
• High-dose chemotherapy before autologous stem-cell transplantation, particularly in multiple myeloma
• Other selected malignancies according to specialist oncology protocols

Dosage Guidelines

Melphalan dosage depends on the indication, formulation, treatment regimen, patient factors, and clinical response.

• Use strictly according to the oncologist’s prescribed protocol.
• Dosing may be based on body surface area or other regimen-specific parameters.
• Complete blood counts should be monitored regularly.
• Renal function should be considered where appropriate.
• Treatment may require dose modification or interruption because of myelosuppression or other toxicity.
• Administration should be supervised by healthcare professionals experienced in oncology treatment.

Wholesale & Supply

Alphalan (Melphalan) may be available for pharmaceutical wholesale and institutional procurement, subject to applicable regulatory requirements.

Bulk procurement enquiries can include:

• Available strengths and presentations
• Packaging configuration
• Certificate of Analysis (CoA)
• Batch information
• Manufacturing documentation
• Export and shipping documentation

Buying Online

Melphalan is a prescription antineoplastic medicine and should be sourced through authorized pharmaceutical distributors, hospitals, pharmacies, or other licensed healthcare channels.

Reviews

Individual responses to Melphalan vary according to the cancer type, treatment regimen, dose, disease status, and patient-specific factors. Treatment response and tolerability should be evaluated by the treating oncology team.

Quality Assurance

Melphalan products should undergo appropriate pharmaceutical quality-control testing according to applicable standards, including testing relevant to identity, potency, purity, and formulation-specific requirements.

Frequently Asked Questions

What is Alphalan used for?

Alphalan contains Melphalan and may be used in chemotherapy protocols for multiple myeloma, ovarian cancer, and selected other malignancies.

What type of medicine is Melphalan?

Melphalan is an alkylating antineoplastic medicine belonging to the nitrogen mustard class.

How does Melphalan work?

Melphalan damages cancer-cell DNA through alkylation and DNA cross-linking, interfering with DNA replication and cell division.

Is Melphalan a chemotherapy medicine?

Yes. Melphalan is a cytotoxic chemotherapy medicine classified as an alkylating agent.

What are the important side effects of Melphalan?

Important adverse effects include bone-marrow suppression, anemia, increased susceptibility to infection, nausea, vomiting, and mucosal effects. Long-term exposure may also be associated with secondary malignancies.

Does Melphalan require blood-count monitoring?

Yes. Regular blood-count monitoring is important because Melphalan can cause significant myelosuppression.

Can Melphalan be used before stem-cell transplantation?

Yes. High-dose Melphalan is commonly used as conditioning therapy before autologous hematopoietic stem-cell transplantation, particularly for multiple myeloma.

Who should administer Alphalan?

Alphalan should be prescribed and administered under the supervision of qualified healthcare professionals experienced in oncology treatment.

Conclusion

Alphalan (Melphalan) is a nitrogen mustard alkylating agent used in specific cancer treatment protocols, particularly for multiple myeloma. By damaging DNA and interfering with cell replication, it helps inhibit the growth of susceptible malignant cells. Because Melphalan can cause significant bone-marrow suppression and other serious toxicities, specialist supervision and appropriate laboratory monitoring are essential.